Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
eXtended Reality for All (XR4ALL)

Framework: Horizon 2020 — Industrial Leadership
Programme: Information and Communication Technologies
Action type: Coordination and support actions
Countries involved: Germany,Belgium,Belgium,Bulgaria,France
Call: Interactive Technologies (H2020-ICT-2018-2, 2018)
Start date: 2018-12-01
End date: 2021-08-31
Duration (months): 33.0
Total project cost (EUR): 2999312.5
EU funding (EUR): 2999312.5
Participants: 6
Project status: CLOSED

Interactive technologies such as Augmented Reality (AR) and Virtual Reality (VR are set to transform the ways in which people communicate, interact and share information. The XR industry is now at a stage where after years of research and development, it has reached a point where technology becomes accessible and allows market introduction. However, the European XR scene is fragmented and there is a risk that big US companies dominate the XR market (what they are already doing B2C). XR4ALL is set to risk through 6 objectives that correspond to the 6 work packages. Together, they will create a thriving European XR community: 1) unite the XR community through the XR Forum (community and supportive portal for knowledge exchange and visibility); 2) provide access to XR solutions on the XR Platform; 3) increase XR innovation through funding of sub-projects, to be integrated in the XR Platform; 4) monitor trends, visions and developments to create a SRIA; 5) boost the take-up of XR through a technology transfer strategy and VC involvement; and 6) carry out efficient dissemination activities to pave the way towards sustainability. All activities are carried out by a consortium of 5 partners with complementary expertise: Coordinator Fraunhofer HHI (XR research), EUN (cascading funding management, access to market and industry users), I3D (10 years of XR community building and events organisation), BCOM (XR platform building and integration) and LucidWeb (XR communication and community building with a strong focus on women in XR).

Keywords: virtual reality,augmented reality,extended reality
Sterile neutrino search in tritium beta decay (SENSE)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: Fundamental constituents of matter
Panel description: Particle, nuclear, plasma, atomic, molecular, gas, and optical physics
Countries involved: Germany
Call: ERC Starting Grant (ERC-2019-STG, 2019)
Start date: 2020-01-01
End date: 2024-12-31
Duration (months): 60.0
Total project cost (EUR): 1733750.0
EU funding (EUR): 978564.0
Participants: 2
Project status: SIGNED

What is the nature of Dark Matter? What is the origin of the neutrino mass? These are two of the most compelling mysteries, physics is facing today. Despite its tremendous success, the Standard Model of Particle Physics does not provide an answer to these questions. Since the Nobel-prize awarded discovery of the neutrino oscillations, which proofs that neutrinos have a mass, the existence of right-handed partners to the known left-handed neutrinos is a basic assumption. This minimal extension of the Standard Model provides a natural mechanism to generate neutrino masses and can lead to the existence of new types of neutrinos, so-called sterile neutrinos. With a mass in the kilo-electron-volt (keV) regime, sterile neutrinos are a prime dark matter candidate. This dark matter type is especially appealing as it can act as warm dark matter, the existence of which would mitigate problems in our understanding of large-scale structures in the cosmos. The existence of sterile neutrinos with a mass in the eV-volt (eV) regime can resolve puzzling experimental anomalies observed in short-baseline neutrino oscillation experiments. With SENSE, I aim to probe the existence of eV – keV sterile neutrino in a laboratory-based experiment with world-leading sensitivity. A unique way to perform this search is via high-precision beta spectroscopy. The novel idea of SENSE is to develop a beyond-the-state-of-the-art Silicon-Drift-Detector system, which, combined with the large-scale Karlsruhe Tritium Neutrino (Katrin) experiment, will open the window to sterile neutrino signals not accessible elsewhere. My role as analysis coordinator of the Katrin experiment and the expertise in semi-conductor detector technology of my independent Max-Planck-Research group put me in the ideal position to conduct this ambitious research project. The discovery of sterile neutrinos would be a breakthrough in science with far-reaching consequences for our understanding of matter and the universe.

Keywords: neutrinos,sterile neutrinos,neutrino mass,dark matter,single beta decay
Study on TRansition and Exclusion in Society of Single-Mums (STRESS-Mums)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Career Restart panel
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: Belgium
Call: Individual Fellowships (H2020-MSCA-IF-2018, 2018)
Start date: 2019-09-02
End date: 2021-10-31
Duration (months): 24.0
Total project cost (EUR): 178320.0
EU funding (EUR): 178320.0
Participants: 1
Project status: CLOSED

Lone motherhood is considered as an increasing social problem, not only because its increase but also since it leads to diverse and separated women having only a partial citizenship. There is little knowledge on the social relations and practices that contribute – or do not contribute – to protecting and socially including lone mothers, beginning from the crucial transition to lone parenthood: the judicial evaluation. Focusing on the transition from double parenthood to lone motherhood and, in particular, on the period of judicial evaluation for child custody and judicial decisions for children/family allowances and divorce/separation, this project aims to investigate some specific aspects of the socio-cultural construction of an active gender citizenship by future lone mothers. The interest is in lone mothers’ everyday strategies and social practices to claim inclusion and to negotiate (or not negotiate) the dominant definition of family and parenthood proposed by institutions and professionals, and the less legitimated and multiple situated definitions of lone parents and their families. Introducing the everyday dimension into the study of gender citizenship has the purpose of exploring the lone mothers’ manifest and hidden ‘work’ of legitimation and of possible de-legitimation by institutions. Adopting the sociological approach of Institutional Ethnography (IE) as a method, this study will collect data in three EU countries (Belgium, Italy and Spain) and in the UK, with discursive interviews to lone mothers, professionals and gender issues activists, participant observations, and photo-voice. The action includes an extensive training in life course studies and gender studies, advanced qualitative methods and academic English language. This action will be hosted by the University of Antwerp, with a secondment phase at the University of Edinburgh and visits at the University of Granada and at the IEN-Institutional Ethnography Nordic Network.

Keywords: lone mothers,gender citizenship,active citizenship,advocacy,everyday life sociology,institutional ethnography
New Oleocanthal-based functional ingredients with anti-inflamatory properties obtained from olive pomace valorisation (NEOCANTAL)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Spain
Call: SME instrument (H2020-SMEInst-2018-2020-1, 2018)
Start date: 2019-02-01
End date: 2019-07-31
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Chronic inflammatory diseases (CID) have dramatically risen in the last decades. Current sole treatment for patients is the long-term intake of nonsteroidal anti-inflammatory drugs with associated harmful side effects, such as ibuprofen, to mitigate their pain. Research has demonstrated that there exist a strong relationship between nutrition and chronic diseases. This way, the extra virgin olive oil’s (EVOO) health effects have been assessed through diverse studies focusing on the Mediterranean diet. Researchers have recognised natural anti-inflammatory properties to oleocanthal, one of the phenols compounds present in the EVOO. Concentration of oleocanthal is 100 times higher in the olive pomace (OP), a highly pollutant by-product from the olive oil industry. Santa Cruz Ingeniería is an agro-industrial engineering firm specialised in agronomic management and R&D. During last years, we have focused on the identification of oleocanthal-rich olive varieties and on the process to obtain stable oleocanthal extracts (Spanish patent application under study). NEOCANTAL is a great Circular Economy opportunity (cumulative turnover of €17.15M three years after its launching) to turn the environmentally harmful and low-cost OP into a valuable raw material for new oleocanthal-rich (60-70% pure) functional ingredients with anti-inflammatory pursposes. It will be produced in three different forms to be added to a wide range of food products: OP powder, liquid and encapsulated oleocanthal. Our target customers are food producers willing to differentiate their products as functional, while our end-users are CID’s patients, but also people who care of their wellbeing or follow healthy trends. In the future, we will address the cosmetics, food packaging and pharma industries. This Feasibility Study’s goal is to deepen in those key points to assess the economic, technical and commercial viability of NEOCANTAL (including a clinical trial) to tackle this challenge for us to scale-up.

Keywords: oleocanthal,polyphenol compounds,olive oil,anti inflammatory,olive pomace,circular economy,functional food,functional ingredient,by product,natural,nutraceutical
Analyzing Smart Bug Tracking and Customer Experience Feedback to Create and Evolve Software Products Users Love (Usersnap Suite)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Austria
Call: SME instrument (H2020-SMEInst-2018-2020-1, 2018)
Start date: 2019-02-01
End date: 2019-07-31
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

In our digital era where most companies will be software dependent at some point, software failure still causes €1.5 trillion of financial loss. We know we have to follow the customer during the development process but half of startups fail because they do not satisfy a customer need . There is a need for a platform that allows easy collecting, logging, tracking and analyzing feedback to inform future product decisions. Usersnap Classic is a visual bug tracking and feedback solution that involves stakeholders across the entire implementation and end-user chain. It is used by web developers, web designers, and customer care managers worldwide. With all the feedback data collected, we want to now scale up to offer Usersnap Suite that allows our customers to understand better what enhancements and features will create the best value for their users and allow them to grow the fastest. The next few years promise to be exciting in terms of the way we tackle business tasks as teams and individuals. This makes way for Usersnap and allows us to tackle a SOM of €1.5 billion that consists of debugging and survey software plus the market we create with our Usersnap Suite. The Usersnap team includes Florian Dorfbauer, the CEO and founder, Haymo Meran, serial founder, and head of product, Josef Trauner, CPO for Usersnap, and Klaus-M. serial founder and our head of growth. We will help our customers make digital experiences exceptional and we will do this by delivering actionable feedback at every step of their digital lifecycle management. Usersnap can make a big contribution to the successful digitization of products and services. The EC launched on 19 April 2016 the first industry-related initiative of the Digital Single Market package. The mid-term review of the Digital Single Market strategy will focus on digitizing the European industry-oriented actions, aiming to manage digital transformation of our society and economy.

Keywords: bug tracking,feedback analysis,product roadmap,digitization of products and services
ground-breaking PEROvskite technologies for advanced X-ray medical Imaging Systems (PEROXIS)

Framework: Horizon 2020 — Industrial Leadership
Programme: Information and Communication Technologies
Action type: Research and Innovation actions
Partnership: Photonics (cPPP)
Countries involved: Spain,Germany,France,France,Netherlands,Netherlands
Call: Application driven Photonics components (H2020-ICT-2019-2, 2019)
Start date: 2020-01-01
End date: 2023-12-31
Duration (months): 48.0
Total project cost (EUR): 5977498.75
EU funding (EUR): 5977498.25
Participants: 9
Project status: SIGNED

The PEROXIS project will develop a new X-ray imaging system with higher sensitivity and spatial resolution compared to conventional ones, which will support diagnosis during intervention and treatments of various diseases. The emerging semiconducting perovskite materials, largely used for photovoltaic applications, are a good candidate since they have the potential to globally address the following ambitious objectives: -Advancing X-ray based imaging systems for advanced diagnostics and treatments of two major diseases: cardiovascular disease (CVD) and stroke -Improving the efficiency and spatial resolution of flat panel X-ray detectors -Groundbreaking perovskite-based direct conversion X-ray imaging detectors for large-area compatibility -Validating the improved image quality of cone beam computed tomography (CBCT) in stroke detection PEROXIS is a multidisciplinary project engaging 7 EU partners from 4 countries (France, Germany, Spain and the Netherlands) covering the academic, RTO and industrial (3 major medical equipment manufacturers) worlds. An implementation plan is presented in the form of 8 work packages, 6 of which are technical in nature. Synergy in communication and dissemination by the several partners and stakeholders (external advisory board mainly composed of physicians who provide letters of intent) will permit to maximize the PEROXIS project impact. Both solutions to overcome the fundamental technological barriers as well as appropriate deliverables, tasks, milestones and risks in order to complete the project objectives in due time are presented. The medical sector will be highly impacted by the PEROXIS project outcome: future applications of an improved PEROXIS imaging system will not be limited to stroke and CVD only, but may be extended to various other clinical domains in which the performance of diagnostic driven therapy systems is limited by current flat panel X-ray detector technology.

Keywords: x ray imaging,cardiovascular disease,chronic obstructive pulmonary disease,perovskite material,x ray detector materials
TRAINING AND RESEARCH FOR SUSTAINABLE SOLUTIONS TO SUPPORT AND SUSTAIN GUT HEALTH AND REDUCE LOSSES IN MONOGASTRIC LIVESTOCK (MonoGutHealth)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Innovative Training Networks (ITN)-European Training Networks
Action type: Marie Skłodowska-Curie actions
Panel: Environment and Geosciences
Countries involved: Ireland,Germany,Belgium,Belgium,Poland,Switzerland,Denmark
Call: Innovative Training Networks (H2020-MSCA-ITN-2020, 2020)
Start date: 2021-01-01
End date: 2024-12-31
Duration (months): 48.0
Total project cost (EUR): 2923819.92
EU funding (EUR): 2923819.92
Participants: 7
Project status: SIGNED

The overall objective of MonoGutHealth is to provide an interdisciplinary, intersectoral and international training experience for ESR’s in an inspiring, novel and highly topical area of livestock research encompassing animal husbandry, social innovations and entrepreneurship. The 11 ESR projects will explore strategies employing nutritional and/or bioactive ingredients to influence perinatal development in monogastrics. The objective being to support optimal microbial colonisation of the gut and healthy body development in pigs and chickens. As a result, livestock will be more resilient to environmental and health challenges and ultimately the number of medicinal treatments will be reduced. MonoGutHealth will contribute to improvements in welfare and in the overall production efficiency of livestock production. Specifically, ESR projects will explore the efficiency of innovative feeding strategies prior to birth and/or during the early neonatal periods to improve the development of the gastrointestinal tract [GIT] and its microbiome and to enhance resilience to pathogen challenges. This will be achieved through intersectoral and synergistic collaborations between industry partners, academic and non-academic beneficiaries to generate innovative tools for more resilient livestock. At the end of this ETN, we will have provided in-depth training in scientific and soft skills for a new ‘breed’ of researchers who can seamlessly cross the traditional discipline boundaries and identify and implement the most appropriate tools required to comprehensively answer pressing current and future challenges in science and/or industry.

Keywords: poultry,perinatal nutrition,microbiome,metabolome,animal health,sustainable livestock,production
Scalable Localization-enabled In-body Terahertz Nanonetwork (ScaLeITN)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Belgium
Call: Individual Fellowships (H2020-MSCA-IF-2019, 2019)
Start date: 2020-06-01
End date: 2022-05-31
Duration (months): 24.0
Total project cost (EUR): 178320.0
EU funding (EUR): 178320.0
Participants: 1
Project status: CLOSED

Nanotechnology is paving the way toward nanoscale devices that are envisioned to enable several groundbreaking healthcare applications, such as molecular-level cancer detection, targeted drug delivery, and neurosurgeries. The nanodevices are expected to flow through the human body, perform actions upon commands or at certain locations, and communicate the results to the outside world. There is, therefore, a need to enable two-way communication between the nanodevices and the outside world, as well as their localization inside the body. These functionalities should be supported while simultaneously maintaining tiny form factors and a low energy consumption profile of a potentially vast number of nanodevices. In the ScaLeITN project, I will utilize wireless signals in the terahertz (THz) frequencies for enabling both localization and communication capabilities for in-body nanodevices. Localization will be enabled through THz backscattering, which is an unexplored paradigm that promises low energy and high precision localization at the nanoscale. The constrained communication range characteristic for in-body THz propagation will be mitigated through multi-hop communication. In such communication, only a selected subset of nanodevices in the multi-hop route will be awoken by utilizing wake-up radio-like signals. Selection of these nanodevices will be based on their location estimates, as well as on their energy lifecycle characterizations if available through backscattering. This is again a novel paradigm that promises enabling low power, reliable, and scalable THz nanocommunication. The main outcome of the project is to develop a pioneering prototype of a THz nanonetwork with both localization and two-way communication capabilities. Market valorization of the prototype is envisioned during and beyond the scope of the project through the Collider and i.start, two academic innovation programmes for supporting scientists in developing disruptive technology-based products.

Keywords: nanocommunication,terahertz,backscatter localization,in body healthcare,prototypical implementation
Optimized drug combinations for effective cancer treatment: a personalised approach. (OPTIM)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: Prevention, Diagnosis and Treatment of Human Diseases
Panel description: Medical technologies and tools for prevention, diagnosis and treatment of human diseases, therapeutic approaches and interventions, pharmacology, preventative medicine, epidemiology and public health, digital medicine
Countries involved: Switzerland
Call: ERC Starting Grant (ERC-2015-STG, 2015)
Start date: 2016-05-01
End date: 2020-04-30
Duration (months): 48.0
Total project cost (EUR): 1199436.0
EU funding (EUR): 1199436.0
Participants: 1
Project status: CLOSED

This project aims to improve the treatment of metastasized colorectal carcinoma (mCRC), as treatment options after first line chemotherapy are desperately needed. The key to improvement of cancer therapy resides in optimal combination of drugs. Optimally combining drugs is non-trivial due to the large number of possibilities, especially when more than two drugs are combined at various doses. In the current research program I propose to use a differential evolution guided stochastic search algorithm to guide the way in finding optimal combination therapies. In previous research I have applied this feedback system control (FSC) technique to navigate through the enormous parametric space of nine angiostatic drugs at four doses. The straightforward iterative approach of in vitro cell viability testing and algorithm-based analysis identified optimal synergistic low-dose drug combinations. In vivo translation by maintaining the drug dose ratio led to effective anti-cancer activity, without evidence of side-effects. A new screen for optimal targeted combination treatment of advanced CRC will be performed. A series of 7 genetically different human CRC cell lines will be used in this screen, thus simulating personalized treatment. The optimized combinations will be ‘ratiometrically’ translated into orthotopic and metastasizing preclinical CRC mouse models and tested in parallel to standard chemotherapy regimens. Development of a method for a personalized screen using freshly isolated tumor cells will prepare the technology for application in the clinic. Using an innovative strategy I previously identified a series of novel markers of the tumor endothelium. After validation of these targets, this project aims for the design of new drugs to be used in a screen for optimal combination therapy for mCRC. The translational and multidisciplinary nature of the current proposal aims for preparing an improved therapeutic combination regimen for testing in cancer patients.

Keywords: anti angiogenesis,drug drug interaction,data modeling,translational approach